Business Description
Harm Reduction Group
ISIN : SE0006261038
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.15 | |||||
Equity-to-Asset | 0.33 | |||||
Debt-to-Equity | 0.35 | |||||
Debt-to-EBITDA | 4.82 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.19 | |||||
Beneish M-Score | -3.21 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EPS without NRI Growth Rate | 42 | |||||
3-Year FCF Growth Rate | 28.5 | |||||
3-Year Book Growth Rate | -2.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 47.04 | |||||
9-Day RSI | 47.6 | |||||
14-Day RSI | 46.11 | |||||
6-1 Month Momentum % | -12.94 | |||||
12-1 Month Momentum % | -51.48 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.23 | |||||
Quick Ratio | 0.4 | |||||
Cash Ratio | 0.03 | |||||
Days Inventory | 242.97 | |||||
Days Sales Outstanding | 40.04 | |||||
Days Payable | 114.91 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -247.9 | |||||
Shareholder Yield % | 101.55 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 46.93 | |||||
Operating Margin % | -8.83 | |||||
Net Margin % | -12.16 | |||||
FCF Margin % | 27.05 | |||||
ROE % | -32.15 | |||||
ROA % | -13.36 | |||||
ROIC % | -13.48 | |||||
ROC (Joel Greenblatt) % | -112.69 | |||||
ROCE % | -14.94 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Price-to-Owner-Earnings | 7.02 | |||||
PS Ratio | 0.23 | |||||
PB Ratio | 0.75 | |||||
Price-to-Free-Cash-Flow | 0.84 | |||||
Price-to-Operating-Cash-Flow | 4.35 | |||||
EV-to-EBIT | -4.12 | |||||
EV-to-EBITDA | 14.11 | |||||
EV-to-Revenue | 0.32 | |||||
EV-to-FCF | 1.27 | |||||
Earnings Yield (Greenblatt) % | -24.33 | |||||
FCF Yield % | 120.35 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Harm Reduction Group Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 173.523 | ||
EPS (TTM) (kr) | -0.076 | ||
Beta | 0 | ||
Volatility % | 68.99 | ||
14-Day RSI | 46.11 | ||
14-Day ATR (kr) | 0.018552 | ||
20-Day SMA (kr) | 0.133325 | ||
12-1 Month Momentum % | -51.48 | ||
52-Week Range (kr) | 0.1 - 0.37 | ||
Shares Outstanding (Mil) | 294.3 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Harm Reduction Group Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Harm Reduction Group Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Harm Reduction Group Frequently Asked Questions
What is Harm Reduction Group(XSAT:NOHARM)'s stock price today?
When is next earnings date of Harm Reduction Group(XSAT:NOHARM)?
Does Harm Reduction Group(XSAT:NOHARM) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |